Pages that link to "Q80597339"
Jump to navigation
Jump to search
The following pages link to Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells (Q80597339):
Displaying 50 items.
- Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials (Q21131223) (← links)
- Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation (Q21284774) (← links)
- Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications (Q26764855) (← links)
- Regulatory dendritic cells for immunotherapy in immunologic diseases (Q26866216) (← links)
- Dendritic cell subsets in type 1 diabetes: friend or foe? (Q26866500) (← links)
- Regulatory dendritic cell therapy: from rodents to clinical application (Q27025996) (← links)
- Targeting dendritic cell function during systemic autoimmunity to restore tolerance (Q27687098) (← links)
- Micro and nanoparticle drug delivery systems for preventing allotransplant rejection (Q28080720) (← links)
- The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape (Q30317628) (← links)
- Regeneration of the pancreatic beta cell (Q33566004) (← links)
- Dendritic cells transduced to express interleukin 4 reduce diabetes onset in both normoglycemic and prediabetic nonobese diabetic mice (Q33649618) (← links)
- Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment (Q33811836) (← links)
- Redox modulation protects islets from transplant-related injury (Q33930274) (← links)
- Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients. (Q34193317) (← links)
- SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling (Q34211024) (← links)
- Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? (Q34338355) (← links)
- The role of dendritic cells in tissue-specific autoimmunity. (Q34422017) (← links)
- Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes (Q34706913) (← links)
- Suppression of Th1-mediated autoimmunity by embryonic stem cell-derived dendritic cells (Q34734082) (← links)
- Dendritic cell control of tolerogenic responses (Q34982085) (← links)
- Current State of Type 1 Diabetes Immunotherapy: Incremental Advances, Huge Leaps, or More of the Same? (Q35116303) (← links)
- Antigen-Specific Therapeutic Approaches in Type 1 Diabetes (Q35762883) (← links)
- Facilitating physiologic self-regeneration: a step beyond islet cell replacement (Q36328926) (← links)
- Characterization of Bone Marrow-Derived Dendritic Cells Developed in Serum-Free Media and their Ability to Prevent Type 1 Diabetes in Nonobese Diabetic Mice (Q36462926) (← links)
- Current and future immunomodulation strategies to restore tolerance in autoimmune diseases (Q36506677) (← links)
- Dendritic cell immunotherapy for autoimmune diabetes (Q36751621) (← links)
- In vivo delivery of nucleic acid-formulated microparticles as a potential tolerogenic vaccine for type 1 diabetes (Q37088220) (← links)
- Immunomodulation of autoimmune diabetes by dendritic cells (Q37150509) (← links)
- A microsphere-based vaccine prevents and reverses new-onset autoimmune diabetes (Q37267841) (← links)
- Antisense makes sense in engineered regenerative medicine (Q37328072) (← links)
- Involvement of suppressive B-lymphocytes in the mechanism of tolerogenic dendritic cell reversal of type 1 diabetes in NOD mice (Q37490637) (← links)
- It's time to bring dendritic cell therapy to type 1 diabetes. (Q37670174) (← links)
- The immunotherapeutic potential of dendritic cells in type 1 diabetes (Q37759033) (← links)
- Gene-environment interaction in type 1 diabetes mellitus (Q37772472) (← links)
- Novel Findings in Drug-Induced Dendritic Cell Tolerogenicity (Q37809070) (← links)
- Multifunctional dendritic cell-targeting polymeric microparticles: engineering new vaccines for type 1 diabetes (Q37820820) (← links)
- Dendritic Cells Modified by Vitamin D: Future Immunotherapy for Autoimmune Diseases (Q37854956) (← links)
- Cell mediators of autoimmune hepatitis and their therapeutic implications (Q38285331) (← links)
- Delivery of siRNAs to Dendritic Cells Using DEC205-Targeted Lipid Nanoparticles to Inhibit Immune Responses (Q38471902) (← links)
- Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes (Q39759808) (← links)
- Immunomodulatory Effects of 1,25-Dihydroxyvitamin D3 on Dendritic Cells Promote Induction of T Cell Hyporesponsiveness to Myelin-Derived Antigens. (Q40516749) (← links)
- Regulatory multitasking of tolerogenic dendritic cells - lessons taken from vitamin d3-treated tolerogenic dendritic cells (Q40674036) (← links)
- Antigen-based immune therapeutics for type 1 diabetes: magic bullets or ordinary blanks? (Q42739489) (← links)
- Interleukin-7 matures suppressive CD127( ) forkhead box P3 (FoxP3)( ) T cells into CD127(-) CD25(high) FoxP3( ) regulatory T cells. (Q45823097) (← links)
- Gene transfer of antisense B7.1 attenuates acute rejection against splenic allografts in rats (Q45873806) (← links)
- Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes. (Q45996564) (← links)
- Update on Dendritic Cell-Induced Immunological and Clinical Tolerance. (Q47121682) (← links)
- Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical Trials (Q47128789) (← links)
- Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective (Q47385058) (← links)
- Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD (Q50350123) (← links)